Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:08 PM ET 10-Q
Financial Results Kairos Pharma, LTD. KAPA

Kairos Pharma Q3 2026 Results: Net Loss of $1.98M, Loss Widens

Kairos Pharma, Ltd. reported a net loss of $5.03 million for the nine months ended September 30, 2026, compared to a $4.08 million loss in the prior year period. The company remains in the development stage with no revenue, and its cash position decreased to $3.13 million as of September 30, 2026, from $4.49 million at year-end 2025.

Key figure
Net loss $1.98M
5:07 PM ET 10-Q
Financial Results Cerenome, Inc. CNSY ▶ Call

Cerenome Q3 2026 Results: Net Loss of $8.66M, Loss Widens

Cerenome, Inc. reported a net loss of $24.6 million for the nine months ended September 30, 2026, compared to a $16.7 million loss in the prior year period. While the company introduced diagnostic revenue of $0.7 million, total revenue decreased due to lower grant revenue, and operating expenses nearly doubled to $25.8 million.

Key figure
Net loss $8.66M
5:07 PM ET 8-K
Financial Results Beasley Broadcast Group Inc BBGI

Beasley Broadcast Group Financial Results

Beasley Broadcast Group reported third quarter 2026 net revenue of $42.8 million, a 16.1% decrease year-over-year driven by weakness in national and local agency advertising. The company reported a net loss of $12.1 million for the quarter but highlighted improved digital operating margins of 32% and the completion of asset sales generating over $10 million in proceeds subsequent to quarter-end.

Term
Q3 2026
5:06 PM ET 8-K
Financial Results Health In Tech, Inc. HIT

Health In Tech Financial Results

Health In Tech reported Q3 2026 revenue of $6.6 million and a net loss of $7.1 million, which included a $5.3 million provision for credit losses. The company highlighted a 15.9% year-over-year growth in distribution partners and a revenue pipeline of $156.4 million as of late October.

Term
Q3 2026

“It is a privilege to lead Health In Tech into its next chapter, and I want to thank Tim Johnson, our founder and Executive Chairman, and the Board for their confidence. Throughout my career, I have focused on scaling businesses, developing growth strategies, and leveraging capital markets to support long-term value creation. I have substantial operational experience scaling new products from incubation to meaningful commercial scale, building”

Sanjay Shrestha, Chief Executive Officer of Health In Tech
5:04 PM ET 10-Q
Financial Results Cheetah Net Supply Chain Service Inc. CTNT

Cheetah Net Supply Chain Service Q3 2026 Results: Net Loss of $2.55M, Loss Widens

Cheetah Net Supply Chain Service Inc. reported a significant increase in revenue to $4.52 million for the nine months ended September 30, 2026, compared to $1.20 million in the prior year. Despite this growth, the company realized a net loss of $3.09 million, driven by high operating expenses and a $2.78 million loss related to the change in fair value of an acquisition-related contingent consideration asset.

Key figure
Net loss $2.55M
5:02 PM ET 10-Q
Financial Results Healthcare Triangle, Inc. HCTI

Healthcare Triangle Q3 2026 Results: Net Loss of $2.53M, Loss Widens

Healthcare Triangle, Inc. reported a significant revenue increase to $28.2 million for the nine months ended September 30, 2026, compared to $10.8 million in the prior year, driven by business expansion. However, the company continues to operate at a loss, with a net loss from operations of $9.7 million for the period and a total asset base that grew to $72.7 million following substantial increases in intangible assets.

Key figure
Net loss $2.53M
5:02 PM ET 10-Q
Financial Results Fly-E Group, Inc. FLYE

Fly-E Group Q2 2026 Results: Net Loss of $1.74M, Loss Narrows

Fly-E Group, Inc. reported a significant decline in revenue to $5.34 million for the six months ended September 30, 2026, compared to $9.24 million in the prior year period. The company's net loss widened to $5.68 million for the same period, driven by decreased gross profit and high general and administrative expenses, raising concerns about its ability to continue as a going concern.

Key figure
Net loss $1.74M
5:02 PM ET 10-Q
Financial Results Presidio Property Trust, Inc. SQFT

Presidio Property Trust Q3 2026 Results: Net Loss of $531K, Loss Narrows

Presidio Property Trust reported a decrease in total revenue to $10.57 million for the nine months ended September 30, 2026, compared to $12.70 million in the prior year period. The company experienced a significant reduction in total assets from $122.1 million at year-end 2025 to $86.3 million, primarily driven by a decrease in real estate assets held for investment.

Key figure
Net loss $531K
5:02 PM ET 10-Q
Financial Results Scientific Industries Inc SCND

Scientific Industries Q3 2026 Results: Net Income $470K, Down 88.2% YoY

Scientific Industries reported a net loss of $2.35 million for the nine months ended September 30, 2026, compared to a net income of $0.69 million in the prior year period. While revenues increased to $4.05 million from $3.43 million, the prior year's profitability was primarily driven by a larger gain on the disposition of discontinued operations.

Key figure
Net income $470K · -88.2% YoY
5:01 PM ET 10-Q
Financial Results Mobiquity Technologies, Inc. MOBQ

Mobiquity Technologies Q3 2026 Results: Net Loss of $3.8M, Loss Widens

Mobiquity Technologies reported a significant revenue increase to $334,896 for the nine months ended September 30, 2026, compared to $160,795 in the prior year. However, net loss widened to $8.6 million due to higher general and administrative expenses, resulting in a total stockholders' deficit of $221,189.

Key figure
Net loss $3.8M
5:01 PM ET 10-Q
Financial Results Positron Corp POSC

Positron Q3 2026 Results: Net Loss of $972K, Loss Narrows

Positron Corp filed its Form 10-Q for the quarterly period ended September 30, 2026, detailing its financial performance and operational progress in the molecular imaging industry. The report highlights the company's focus on its PET imaging systems and the development of its radiopharmaceutical business segments.

Key figure
Net loss $972K
5:01 PM ET 10-Q
Financial Results Calidi Biotherapeutics, Inc. CLDI

Calidi Biotherapeutics Q3 2026 Results: Net Loss of $3.65M, Loss Narrows

Calidi Biotherapeutics reported a net loss of $11.9 million for the nine months ended September 30, 2026, compared to a $16.0 million loss in the prior year period. The company maintained a cash balance of $3.9 million as of September 30, 2026, and completed a 1-for-16 reverse stock split in July 2026 to adjust its capital structure.

Key figure
Net loss $3.65M
5:01 PM ET 10-Q
Financial Results EQT Private Equity Co LLC

EQT Private Equity Co Q3 2026 Results: Net Income $48.7M, Up 75.1% YoY

EQT Private Equity Company LLC reported total investments at fair value of $997.7 million as of September 30, 2026, representing a significant increase from $602.9 million at the end of 2025. The company maintains a diverse share structure across multiple classes and reported $165.6 million in cash and cash equivalents to support its ongoing private equity acquisition strategy.

Key figure
Net income $48.7M · +75.1% YoY
5:01 PM ET 10-Q
Financial Results Stardust Power Inc. SDST

Stardust Power Q3 2026 Results: Net Loss of $2.77M, Loss Narrows

Stardust Power Inc. reported total assets of $13.4 million and total liabilities of $15.4 million as of September 30, 2026, resulting in a stockholders' deficit. The company faces substantial doubt regarding its ability to continue as a going concern following its delisting from Nasdaq and transition to the Pink Limited Market.

Key figure
Net loss $2.77M
5:01 PM ET 10-K
Financial Results Guru App Factory Corp GAFC

Guru App Factory FY 2026 Results: Net Loss of $59.4K, Loss Widens

Guru App Factory Corp reported a decline in revenue from $94,500 in 2025 to $52,000 in 2026, primarily due to the non-recurrence of a large software development order. The company's net loss widened to $59,440, and its independent auditor issued a going concern warning due to a working capital deficit and accumulated deficit of $126,863.

Key figure
Net loss $59.4K
5:01 PM ET 10-Q
Financial Results Highview Merger Corp. HVMC

Highview Merger Q3 2026 Results: Net Income $1.81M, Up 82.9% YoY

Highview Merger Corp. reported a net income of $5.37 million for the nine months ended September 30, 2026, primarily driven by $6.24 million in interest earned on marketable securities held in the Trust Account. As a shell company, its activities are focused on identifying a target for a business combination, with $239.85 million currently held in trust for potential redemptions.

Key figure
Net income $1.81M · +82.9% YoY
5:01 PM ET 10-Q
Financial Results EQT Infrastructure Co LLC

EQT Infrastructure Co Q3 2026 Results: Net Income $41.5M

EQT Infrastructure Company LLC reported total investments at fair value of $886.6 million as of September 30, 2026, a significant increase from zero at the end of 2025 following its initial offering in February 2026. The company maintains a complex share structure with over 44 million shares outstanding across various classes, primarily focused on acquiring and managing portfolio companies through joint ventures.

Key figure
Net income $41.5M
5:01 PM ET 10-Q
Financial Results Twelve Seas Investment Co III TWLV

Twelve Seas Investment Co III Q3 2026 Results: Turns Profitable, Net Income $1.46M

Twelve Seas Investment Company III is a shell company that completed its IPO on December 15, 2025, raising $172.5 million held in trust. As of September 30, 2026, the company has 17,745,000 Class A and 5,692,500 Class B ordinary shares outstanding and is seeking a business combination within a 24-month window ending December 15, 2027.

Key figure
Net income $1.46M
5:01 PM ET 8-K
Financial Results Beyond Air, Inc. XAIR

Beyond Air Financial Results

Beyond Air reported record quarterly revenue of $2.3 million for the period ended September 30, 2026, representing 28% year-over-year growth. The company reaffirmed its revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027 while awaiting FDA approval for its second-generation LungFit PH system.

Term
Q2 2027

“Building on the commercial momentum we are generating with our first-generation LungFit PH system, we believe our second-generation system has the potential to substantially expand our market opportunity and accelerate growth, pending FDA approval.”

Robert Goodman, Chief Executive Officer of Beyond Air

“We remain encouraged by our active and productive discussions with the FDA and the progress we are making toward completing the remaining steps in the review process for the second-generation LungFit PH system.”

Robert Goodman, Chief Executive Officer of Beyond Air
5:00 PM ET 10-Q
Financial Results Spruce Power Holding Corp SPRU ▶ Call

Spruce Power Holding Q3 2026 Results: Turns Profitable, Net Income $6.03M

Spruce Power Holding Corp reported 19,294,133 shares of common stock outstanding as of November 9, 2026. The company's cash and cash equivalents decreased from $54.8 million at the end of 2025 to $40.1 million as of September 30, 2026, while management highlighted risks related to debt refinancing and solar industry demand.

Key figure
Net income $6.03M
5:00 PM ET 8-K
Financial Results Evofem Biosciences, Inc. EVFM

Evofem Biosciences Financial Results

Evofem Biosciences reported Q3 2026 financial results, achieving $0.7 million in operating income despite a slight decline in net sales to $4.6 million. The company highlighted the shipment of its 500,000th box of PHEXX and the addition of a fifth study site for an NIH-funded Phase 4 trial of SOLOSEC.

Term
Q3 2026

“While third quarter net sales reflect the cumulative impact of operating without dedicated growth capital for brand promotion and physician outreach since late 2022, we are proud of the discipline, efficiency and tenacity demonstrated across the organization. Through rigorous expense management, we generated $0.7 million of operating income during the quarter while continuing to support patients and healthcare providers who rely on our innovative sexual health products.”

Saundra Pelletier, CEO of Evofem
4:59 PM ET 10-Q
Financial Results BioScience Health Innovations, Inc. BHIC

BioScience Health Innovations Q3 2026 Results: Net Loss of $149K, Loss Widens

BioScience Health Innovations, Inc. reported a net loss of $564,885 for the nine months ended September 30, 2026, a significant decline from the $875,720 net income in the prior year period. Despite the loss, the company successfully raised over $2 million through common stock sales, ending the period with a strengthened cash position of $1,691,858.

Key figure
Net loss $149K
4:58 PM ET 10-Q
Financial Results KKR Private Equity Conglomerate LLC

KKR Private Equity Conglomerate Q3 2026 Results: Net Income $351M, Up 12.4% YoY

KKR Private Equity Conglomerate LLC reported a net increase in net assets resulting from operations of $975.5 million for the nine months ended September 30, 2026, compared to $762.1 million in the prior year period. Total assets grew to $13.6 billion, driven by a significant increase in investments at fair value and cash holdings.

Key figure
Net income $351M · +12.4% YoY
4:58 PM ET 10-Q
Financial Results Evofem Biosciences, Inc. EVFM

Evofem Biosciences Q3 2026 Results: Turns Profitable, Net Income $1M

Evofem Biosciences reported a significant decline in total assets from $20.3 million at year-end 2025 to $7.3 million as of September 30, 2026, driven largely by a decrease in trade accounts receivable and intangible assets. The company faces substantial liquidity challenges with $84.8 million in current liabilities and has received notices of default from Future Pak, LLC regarding its debt obligations.

Key figure
Net income $1M
4:56 PM ET 10-Q
Financial Results Senior Credit Investments, LLC

Senior Credit Investments Q3 2026 Results: Net Income $6.96M, Up 68.5% YoY

Senior Credit Investments, LLC reported a net increase in member’s capital resulting from operations of $18.4 million for the nine months ended September 30, 2026, up from $12.0 million in the prior year period. Total investment income grew significantly to $40.4 million, driven by interest income from its non-controlled/non-affiliated investment portfolio, while net asset value per unit decreased slightly to $1,767.94 from $1,787.98 at year-end 2025.

Key figure
Net income $6.96M · +68.5% YoY
4:56 PM ET 10-Q
Financial Results Jefferies Credit Partners BDC Inc.

Jefferies Credit Partners BDC Q3 2026 Results: Net Income $20.9M, Up 73.5% YoY

Jefferies Credit Partners BDC Inc. reported a net increase in net assets resulting from operations of $52.0 million for the nine months ended September 30, 2026, compared to $30.5 million for the same period in 2025. Total net assets grew to $964.9 million from $677.0 million at year-end 2025, driven by significant capital share issuances and investment income growth.

Key figure
Net income $20.9M · +73.5% YoY
4:56 PM ET 10-Q
Financial Results 21Shares Solana Staking ETF TSOL

21Shares Solana Staking ETF Q3 2026 Results: Net Income $2.23M

The 21Shares Solana Staking ETF reported net assets of $9,786,070 as of September 30, 2026, a significant increase from $5,735,019 at the end of 2025. The Trust generated $102,143 in staking rewards for the nine months ended September 30, 2026, and transitioned its pricing benchmark to the FTSE Solana Index in August 2026.

Key figure
Net income $2.23M
4:55 PM ET 10-Q
Financial Results Blue Line Holdings, Inc. BLNH

Blue Line Holdings Q1 2026 Results: Net Loss of $12.5K, Loss Widens

Blue Line Holdings, Inc. remains a pre-revenue industrial company with a net loss of $12,459 for the quarter ended September 30, 2026. The company reported a working capital deficit of $90,521 and expressed substantial doubt regarding its ability to continue as a going concern without additional financing.

Key figure
Net loss $12.5K
4:55 PM ET 10-Q
Financial Results Inve Technologies, Inc. INVE

Inve Technologies Q3 2026 Results: Turns Profitable, Net Income $588K

For the quarter ended September 30, 2026, INVE Technologies reported a net income of $0.6 million, a significant improvement from a $3.5 million loss in the prior year, primarily driven by a $6.1 million gain on an asset sale. However, total revenue decreased to $3.1 million from $5.0 million year-over-year, and the company recorded a nine-month net loss of $7.5 million.

Key figure
Net income $588K
4:55 PM ET 10-Q
Financial Results Femasys Inc FEMY

Femasys Q3 2026 Results: Net Loss of $4.56M, Loss Widens

Femasys Inc. reported a decrease in sales for the nine months ended September 30, 2026, totaling $1,161,313 compared to $1,479,926 in the prior year period. The company significantly strengthened its balance sheet, ending the quarter with $23.9 million in cash and cash equivalents following financing activities, while maintaining an accumulated deficit of $154 million.

Key figure
Net loss $4.56M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.